Learn Mode
CLOV logo

CLOV - Clover Health Investments Corp

47


$1.70

-$0.06 (-3.148%)
4/1/26, 5:21 PM
Stock Unlock LogoScore

2.48/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
CLOV
Valuation Score
View as %

Stock Unlock Logo
Stock Unlock
$1.69$3.86AprJunAugOctDecFeb

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Stock Profile
  • Market Cap
    $724.03M
  • Industry
    Health Care
  • EPS (TTM)
    -$0.17
  • P/E (TTM)
    0.00
  • Div & Yield
    --
  • FCF Payout Ratio
    --
  • P/S (TTM)
    0.38
  • P/B
    2.35
  • Diluted Shares
    517.30M
  • Ex-Dividend
    --
  • Next Earnings
    05-04
  • Forward P/E
    47.75
  • Payout Ratio
    --
  • P/FCF (TTM)
    0.00
  • FCF Yield
    --
  • Earnings Yield
    -11.82%
  • 52 Week Range
2.48
Bad
Clover Health Investments Corp has negative free cash flow of -68.98M, which means it is currently losing money. Also, it has a current cash runway of 20.92 months. The cash runway is the amount of time the business has at its current burn rate before it will need to take on debt or dilute shareholders to raise more money.
Valuation Model
Key Score
4.00
Good
Management
3.00
Average

Growth
5.00
Very Good

Profitability
3.00
Average
Fin. Health
3.00
Average

Dividends
--
--

Analyst
1.00
Very Bad
Insider Transactions
Explore Insider Tab
Buy
Sell
202120222023202420252026$0$7M$13M$20M$26M
Market News
Page 1 of 21
Form SCHEDULE 13G/A
Unknown Form Type

Filed on 2026-03-26 17:13:27


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-18 18:11:18


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-18 16:32:05


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:33:00


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:30:54


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:27:13


Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Filed on 2026-03-09 17:41:31


Form 8-K/A
(Amendment) Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-06 09:06:35


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-06 08:46:27


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-05 16:16:16


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-04 17:38:50


Form 10-K
Annual financials report pursuant to Section 13 or 15(d)

Filed on 2026-02-27 08:08:29

Page 1 of 21
Revenue
Earnings
Free Cash Flow
2022202320242025-$1.20B$0$1.20B$2.40B$3.60B
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-03-25
High:
$3.36
97.1%
Avg:
$2.60
52.6%
Low:
$1.77
3.7%
(% change is relative to the current stock price: $1.70)
Analyst Recommendations
Go to Analyst Tab
3.80
Good
20%
Strong Buy (2)
40%
Buy (4)
40%
Hold (4)
0%
Sell (0)
0%
Strong Sell (0)
About
Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 724 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
  • IPO Date
    2020-06-12
  • Industry
    Health Care
  • Total Employees
    570
  • Exchange
    Nasdaq Nms - Global Market
  • Reporting Currency
    USD
  • GICS
    Health Care Providers & Services
  • GICS Sub
    Managed Health Care
  • GICS Sector
    Health Care
  • GICS Group
    Health Care Equipment & Services